Security Snapshot

ISHARES TR - ISHS 1-5YR INVS (IGSB) Institutional Ownership

CUSIP: 464288646

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

1,007

Shares (Excl. Options)

308,262,211

Price

$52.41

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.07%
Share change
+8,096,658
Value change
+$423,833,693
Number of holders
1,007
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$52.18
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IGSB - ISHARES TR - ISHS 1-5YR INVS is tracked under CUSIP 464288646.
  • 1007 institutions reported positions in Q2 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 1,020 to 1,007 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $15,714,220,878 to $16,154,843,565.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1007 institutions filings for Q2 2026.

Open SEC evidence

Security key

464288646

Latest holder period

Q2 2026

13F holders

1,007

13D/G owners

0

CIK / CUSIP context first

As of 30 Jun 2026, 1,007 institutional investors reported holding 308,262,211 shares of ISHARES TR - ISHS 1-5YR INVS (IGSB).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 308,262,211 $16,154,843,565 +$423,833,693 $52.41 1,007
2026 Q1 298,942,011 $15,714,220,878 -$28,030,058 $52.56 1,020
2025 Q4 300,664,583 $15,904,583,007 +$181,736,348 $52.88 1,013
2025 Q3 288,893,553 $15,324,969,699 -$685,683,579 $53.03 947
2025 Q2 311,850,796 $16,452,685,978 -$13,709,084 $52.76 939
2025 Q1 311,905,759 $16,340,983,317 +$231,017,102 $52.37 935
2024 Q4 310,570,007 $16,055,133,259 +$327,055,663 $51.70 953
2024 Q3 300,909,562 $15,844,553,363 +$256,098,259 $52.66 888
2024 Q2 295,960,079 $15,164,920,160 -$817,377,032 $51.24 872
2024 Q1 311,869,785 $15,990,234,503 -$365,619,240 $51.28 884
2023 Q4 318,216,469 $16,309,271,098 -$1,227,378,045 $51.28 910
2023 Q3 338,811,852 $16,885,090,168 -$334,817,007 $49.83 870
2023 Q2 343,839,233 $17,258,616,524 -$284,945,491 $50.17 876
2023 Q1 350,134,177 $17,695,518,056 +$156,338,970 $50.54 897
2022 Q4 357,837,901 $17,822,093,893 +$1,148,431,680 $49.82 914
2022 Q3 295,360,226 $14,551,263,827 -$194,089,907 $49.28 864
2022 Q2 298,994,705 $15,116,786,439 +$348,247,684 $50.55 894
2022 Q1 292,549,164 $15,134,875,333 -$211,254,945 $51.72 915
2021 Q4 297,256,352 $16,017,213,740 -$1,570,384,023 $53.88 940
2021 Q3 318,474,570 $17,402,920,607 -$2,233,596,276 $54.64 899
2021 Q2 365,014,959 $20,005,562,750 +$1,609,386,058 $54.81 893
2021 Q1 335,390,202 $18,336,838,961 +$1,773,398,617 $54.68 891
2020 Q4 301,840,106 $16,647,579,619 +$1,713,092,626 $55.17 887
2020 Q3 252,404,373 $13,856,587,599 +$1,849,145,404 $54.91 785
2020 Q2 219,527,610 $12,010,029,177 +$2,958,331,514 $54.71 764
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .